title: Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Antar
authors.forename: Z K
authors.initials: ZK
authors.lastname: Otrock
authors.forename: M
authors.initials: M
authors.lastname: Kharfan-Dabaja
authors.forename: Z
authors.initials: Z
authors.lastname: Salem
authors.forename: S
authors.initials: S
authors.lastname: Aractingi
authors.forename: M
authors.initials: M
authors.lastname: Mohty
authors.forename: A
authors.initials: A
authors.lastname: Bazarbachi
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001374:Azacitidine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000517:prevention & control; D008297:Male; D009062:Mouth Neoplasms / Q000517:prevention & control / Q000628:therapy; D012008:Recurrence; D012878:Skin Neoplasms / Q000517:prevention & control / Q000628:therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine